Literature DB >> 16624459

Timing and presentation of recurrent oral and oropharyngeal squamous cell carcinoma and awareness in the outpatient clinic.

D Kissun1, P Magennis, D Lowe, J S Brown, E D Vaughan, S N Rogers.   

Abstract

The aim of this study was to assess the timing of outpatient review appointments in relation to tumour recurrence. A retrospective review of 278 consecutive previously untreated patients with oral and oropharyngeal squamous cell carcinoma (SCC) between 1995 and 1999 was performed. Information on the time of recurrence, site, presentation, treatment and outcome was collected. There were 54 (19%) patients who developed recurrent disease. Recurrence occurred at a median time of 8 months after the initial operation and most (49/54) within 2 years. Thirty-five patients (65%) presented with a new lump (7 local, 22 regional and 5 locoregional). Our policy is to review patients once a month for the first year and every other month for the second year. Patients were seen less frequently than expected, and one in five patients attended half or less than half as frequently as intended in the first year. Although 20 patients were aware of new symptoms from their recurrent disease fewer than half (9) brought their appointment forward. This study has emphasised the need for close clinical follow-up of patients previously treated for oral/oropharyngeal SCC if recurrent tumours are to be discovered and treated at the earliest opportunity.

Entities:  

Mesh:

Year:  2006        PMID: 16624459     DOI: 10.1016/j.bjoms.2005.08.010

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  20 in total

1.  (18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.

Authors:  Thomas Bird; Sally Barrington; Selvam Thavaraj; Jean-Pierre Jeannon; Andrew Lyons; Richard Oakley; Ricard Simo; Mary Lei; Teresa Guerrero Urbano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-28       Impact factor: 9.236

2.  Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.

Authors:  Sweet Ping Ng; Courtney Pollard; Joel Berends; Zeina Ayoub; Mona Kamal; Adam S Garden; Houda Bahig; Scott B Cantor; Andrew J Schaefer; Temitayo Ajayi; G Brandon Gunn; Steven J Frank; Heath Skinner; Jack Phan; William H Morrison; Renata Ferrarotto; Jason M Johnson; Abdallah S R Mohamed; Stephen Y Lai; Amy C Hessel; Erich M Sturgis; Randal S Weber; Clifton D Fuller; David I Rosenthal
Journal:  Cancer       Date:  2019-02-12       Impact factor: 6.860

3.  Disparities in adherence to head and neck cancer follow-up guidelines.

Authors:  Haley K Perlow; Stephen J Ramey; Vincent Cassidy; Deukwoo Kwon; Benjamin Farnia; Elizabeth Nicolli; Michael A Samuels; Laura Freedman; Nagy Elsayyad; Raphael Yechieli; Stuart E Samuels
Journal:  Laryngoscope       Date:  2018-12-24       Impact factor: 3.325

Review 4.  Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma.

Authors:  Antoine Digonnet; Marc Hamoir; Guy Andry; Missak Haigentz; Robert P Takes; Carl E Silver; Dana M Hartl; Primož Strojan; Alessandra Rinaldo; Remco de Bree; Andreas Dietz; Vincent Grégoire; Vinidh Paleri; Johannes A Langendijk; Vincent Vander Poorten; Michael L Hinni; Juan P Rodrigo; Carlos Suárez; William M Mendenhall; Jochen A Werner; Eric M Genden; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-13       Impact factor: 2.503

5.  Survivorship care experiences, information, and support needs of patients with oral and oropharyngeal cancer.

Authors:  Sharon Manne; Shawna V Hudson; Soly Baredes; Antoinette Stroup; Shannon Myers Virtue; Lisa Paddock; Evelyne Kalyoussef
Journal:  Head Neck       Date:  2016-01-20       Impact factor: 3.147

6.  Fear of recurrence following head and neck cancer in the outpatient clinic.

Authors:  S N Rogers; B Scott; D Lowe; G Ozakinci; G M Humphris
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-27       Impact factor: 2.503

Review 7.  Current concepts of surveillance and its significance in head and neck cancer.

Authors:  Kapila Manikantan; Raghav C Dwivedi; Suhail I Sayed; K A Pathak; Rehan Kazi
Journal:  Ann R Coll Surg Engl       Date:  2011-11       Impact factor: 1.891

8.  Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.

Authors:  Lale Kostakoglu; Reza Fardanesh; Marshall Posner; Peter Som; Srikar Rao; Eunice Park; John Doucette; Evan G Stein; Vishal Gupta; Krzysztof Misiukiewicz; Eric Genden
Journal:  Oncologist       Date:  2013-09-13

Review 9.  Post-therapeutic surveillance schedule for oral cancer: is there agreement?

Authors:  Guicai Liu; Eric J Dierks; R Bryan Bell; Tuan G Bui; Bryce E Potter
Journal:  Oral Maxillofac Surg       Date:  2012-09-02

Review 10.  Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience.

Authors:  Nerina Denaro; Marco Carlo Merlano; Elvio Grazioso Russi
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-06-25       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.